Human heart-in-a-jar

Heart failure with preserved ejection fraction is a condition where the heart still pumps but is too weak to fill properly with blood.  Many obscure factors contribute to this, which is why AstraZeneca and a Canadian partner, Novoheart (Vancouver, BC) are collaborating to create heart organoids for drug testing.  These organoids are made with specific cellular and matrix ingredients and patient specific iPSCs—presumably in a container of some sort, perhaps a jar.  MORE

Image Credit:  AstraZeneca and Novoheart